This tag is created dynamically through created issue pages
In comments sent today to CMS and OMB on its information collection for developing an Inpatient Rehabilitation Facility (IRF) Review Choice Demonstration, FAH urged CMS to withdraw the proposed program that would require either 100 […]
Read More… from FAH Opposes IRF Review Choice Demo in Comments to CMS
In comments submitted today, FAH reiterated its full support for CMS’s prospective budget-neutral 340B payment policy to continue to pay Average Sales Price (ASP) minus 22.5 percent for 340B-acquired drugs. “We agree with CMS that […]
Read More… from FAH Comments on CY 2022 Medicare OPPS Proposed Rule
